Cobiz Investment Management LLC raised its stake in shares of CVS Health Corporation (NYSE:CVS) by 0.2% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 32,936 shares of the pharmacy operator’s stock after buying an additional 69 shares during the period. Cobiz Investment Management LLC’s holdings in CVS Health Corporation were worth $2,931,000 as of its most recent filing with the SEC.

Several other institutional investors have also bought and sold shares of the stock. Acrospire Investment Management LLC raised its position in CVS Health Corporation by 542.2% in the second quarter. Acrospire Investment Management LLC now owns 1,066 shares of the pharmacy operator’s stock valued at $102,000 after buying an additional 900 shares during the last quarter. MU Investments Co. Ltd. raised its position in CVS Health Corporation by 62.0% in the second quarter. MU Investments Co. Ltd. now owns 1,150 shares of the pharmacy operator’s stock valued at $109,000 after buying an additional 440 shares during the last quarter. Pinkerton Retirement Specialists LLC raised its position in CVS Health Corporation by 3,475.0% in the second quarter. Pinkerton Retirement Specialists LLC now owns 1,144 shares of the pharmacy operator’s stock valued at $110,000 after buying an additional 1,112 shares during the last quarter. D Orazio & Associates Inc. raised its position in CVS Health Corporation by 9.4% in the second quarter. D Orazio & Associates Inc. now owns 1,160 shares of the pharmacy operator’s stock valued at $111,000 after buying an additional 100 shares during the last quarter. Finally, Cantab Capital Partners LLP raised its position in CVS Health Corporation by 355.4% in the second quarter. Cantab Capital Partners LLP now owns 1,184 shares of the pharmacy operator’s stock valued at $113,000 after buying an additional 924 shares during the last quarter. Institutional investors and hedge funds own 80.44% of the company’s stock.

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

CVS Health Corporation (NYSE:CVS) traded up 0.97% on Monday, reaching $74.78. 8,625,052 shares of the company’s stock traded hands. The firm’s 50-day moving average is $81.47 and its 200 day moving average is $91.44. CVS Health Corporation has a 52-week low of $69.30 and a 52-week high of $106.67. The stock has a market capitalization of $79.75 billion, a PE ratio of 16.03 and a beta of 0.88.

CVS Health Corporation (NYSE:CVS) last posted its earnings results on Tuesday, November 8th. The pharmacy operator reported $1.64 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.57 by $0.07. CVS Health Corporation had a net margin of 2.96% and a return on equity of 17.18%. The business had revenue of $44.60 billion for the quarter, compared to analyst estimates of $45.29 billion. During the same period last year, the business posted $1.28 EPS. CVS Health Corporation’s revenue was up 15.5% compared to the same quarter last year. Analysts forecast that CVS Health Corporation will post $5.81 EPS for the current year.

The company also recently announced a quarterly dividend, which was paid on Thursday, November 3rd. Investors of record on Monday, October 24th were paid a $0.425 dividend. The ex-dividend date was Thursday, October 20th. This represents a $1.70 dividend on an annualized basis and a yield of 2.28%. CVS Health Corporation’s payout ratio is presently 36.40%.

ILLEGAL ACTIVITY NOTICE: “Cobiz Investment Management LLC Acquires 69 Shares of CVS Health Corporation (CVS)” was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece on another site, it was copied illegally and reposted in violation of international trademark and copyright laws. The correct version of this piece can be read at https://www.thecerbatgem.com/2016/11/28/cobiz-investment-management-llc-acquires-69-shares-of-cvs-health-corporation-cvs.html.

Several equities analysts recently weighed in on the stock. Mizuho lifted their target price on shares of CVS Health Corporation from $108.00 to $111.00 and gave the company a “buy” rating in a report on Thursday, August 4th. Citigroup Inc. cut their price objective on shares of CVS Health Corporation from $115.00 to $108.00 and set a “neutral” rating on the stock in a report on Monday, August 8th. Vetr upgraded shares of CVS Health Corporation from a “buy” rating to a “strong-buy” rating and set a $98.36 price objective on the stock in a report on Monday, October 24th. Leerink Swann reiterated a “buy” rating on shares of CVS Health Corporation in a report on Wednesday, August 3rd. Finally, Credit Suisse Group AG reiterated a “buy” rating and issued a $115.00 price objective on shares of CVS Health Corporation in a report on Tuesday, September 20th. Five investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the company. The stock has a consensus rating of “Buy” and an average price target of $106.24.

About CVS Health Corporation

CVS Health Corporation, together with its subsidiaries (CVS Health), is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail/LTC and Corporate. The Company offers a range of products and services, such as advising patients on their medications at its CVS Pharmacy locations, introducing programs to help control costs for its clients at CVS Caremark, how care is delivered to its patients with conditions through CVS Specialty, pharmacy care for the senior community through Omnicare.

5 Day Chart for NYSE:CVS

Receive News & Stock Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related stocks with our FREE daily email newsletter.